Crossmark

Hybrid derivatives containing dimethyl fumarate and benzothiazole scaffolds for the potential treatment of multiple sclerosis; in silico & in vivo study

Crossref DOI link: https://doi.org/10.1007/s40199-024-00529-8

Published Online: 2024-08-06

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Mirmotahari, Seyedeh Azin

Aliomrani, Mehdi

Hassanzadeh, Farshid

Sirous, Hajar

Rostami, Mahboubeh https://orcid.org/0000-0001-9968-821X
License Information

Text and Data Mining valid from 2024-08-06

Version of Record valid from 2024-08-06
More Information

Article History

Received: 12 November 2022

Accepted: 30 June 2024

First Online: 6 August 2024

Declarations

:

: There are no conflicts of interest declared by the authors.

Document is current

Any future updates will be listed below